Given what happened with the recent Sirtex study results, it'll be interesting to see how any results around alleviating pain/improving quality of life will be leveraged, as opposed to reduction in size of tumour and life expectancy.
Life expectancy is rubbish with these cancers and I'd have thought that improvement in quality of life will be an important outcome, even if life expectancy dial does not move significantly...
Ann: Appendix 4C and Quarterly update, page-6
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.002(16.7%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.2¢ | $170.2K | 13.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1581235 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 9880504 | 9 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |